NorthView Acquisition (NVACR) Competitors $0.03 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NVACR vs. DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, HSCSW, BEATW, LUCYW, IINNW, and NXGLWShould you be buying NorthView Acquisition stock or one of its competitors? The main competitors of NorthView Acquisition include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), and NEXGEL (NXGLW). These companies are all part of the "medical equipment" industry. NorthView Acquisition vs. Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NEXGEL Alpha Tau Medical (NASDAQ:DRTSW) and NorthView Acquisition (NASDAQ:NVACR) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations. Is DRTSW or NVACR more profitable? Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A N/A N/A NorthView Acquisition N/A N/A N/A Does the media refer more to DRTSW or NVACR? In the previous week, Alpha Tau Medical had 3 more articles in the media than NorthView Acquisition. MarketBeat recorded 4 mentions for Alpha Tau Medical and 1 mentions for NorthView Acquisition. NorthView Acquisition's average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.47 indicating that NorthView Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Alpha Tau Medical Neutral NorthView Acquisition Very Positive Does the MarketBeat Community favor DRTSW or NVACR? Alpha Tau Medical and NorthView Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlpha Tau MedicalN/AN/ANorthView AcquisitionN/AN/A Which has better earnings and valuation, DRTSW or NVACR? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/AN/AN/AN/ANorthView AcquisitionN/AN/AN/AN/AN/A SummaryAlpha Tau Medical and NorthView Acquisition tied by winning 1 of the 2 factors compared between the two stocks. Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Get NorthView Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for NVACR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVACR vs. The Competition Export to ExcelMetricNorthView AcquisitionSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$437,500.00$2.16B$8.74BDividend YieldN/AN/A2.54%4.07%P/E RatioN/AN/A27.2413.27Price / SalesN/A0.00164.3681.14Price / CashN/AN/A0.0135.77Price / BookN/AN/A1.525.92Net IncomeN/AN/A$257.43M$225.73M7 Day PerformanceN/A7.91%-1.54%-1.34%1 Month PerformanceN/A23.97%-0.73%1.15%1 Year PerformanceN/A14.33%10.72%24.02% NorthView Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVACRNorthView AcquisitionN/A$0.03flatN/A-75.4%$0.00N/A0.002Positive NewsGap UpHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.20flatN/A-37.3%$0.00N/A0.0080News CoverageANZUWAnzu Special Acquisition Corp IN/A$0.09flatN/A+211.0%$0.00N/A0.002Gap DownBBLGWBone BiologicsN/A$28.49-10.4%N/AN/A$0.00N/A0.002News CoveragePositive NewsGap DownBRSHWBruush Oral CareN/A$0.01flatN/AN/A$0.00$2.92M0.0011GMVDWG Medical InnovationsN/A$0.02flatN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.03flatN/AN/A$0.00$18,600.000.0010News CoveragePositive NewsBEATWHeartBeamN/A$0.72+2.9%N/A+170.2%$0.00N/A0.005Short Interest ↑Gap DownLUCYWInnovative EyewearN/A$0.04-20.1%N/A-61.5%$0.00$1.53M0.009Short Interest ↑News CoverageIINNWInspira Technologies Oxy B.H.N.N/A$0.31-6.1%N/A+52.8%$0.00N/A0.0020NXGLWNEXGELN/A$0.72+10.8%N/A+74.4%$0.00$5.01M0.0010Positive NewsGap Down Related Companies and Tools Related Companies DRTSW Alternatives ANZUW Alternatives BBLGW Alternatives BRSHW Alternatives GMVDW Alternatives HSCSW Alternatives BEATW Alternatives LUCYW Alternatives IINNW Alternatives NXGLW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NVACR) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NorthView Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NorthView Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
